Filip De Vos

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial”.

Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial

Nature Medicine(2023)10.1038/s41591-023-02321-8

N/A

4.1DataRank · unranked

307 citations

Robert J. Kreitman, Zev A. Wainberg, Anas Gazzah, Ulrik Lassen, Alexander Stein +18 more

Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS -mutant Melanoma

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3872

N/A

1.6DataRank · unranked

44 citations

Lisa Zimmer, Kevin B. Kim, Jeffrey A. Sosman, Paolo A. Ascierto, Michael A. Postow +10 more

Radiosynthesis, in vitro and preliminary in vivo evaluation of the novel glutamine derived PET tracers [18F]fluorophenylglutamine and [18F]fluorobiphenylglutamine

Nuclear Medicine and Biology(2020)10.1016/j.nucmedbio.2020.03.006

N/A

0DataRank · unranked

7 citations

Jeroen Verhoeven, Glenn Pauwelyn, Ji‐Yun Hu, Patricia Lambe, Stef De Lombaerde +8 more

Depatuxizumab mafodotin in EGFR-amplified newly diagnosed glioblastoma: A phase III randomized clinical trial

Neuro-Oncology(2022)10.1093/neuonc/noac173

N/A

0DataRank · unranked

153 citations

Stephanie L. Pugh, Tony J. C. Wang, Kenneth Aldape, Hui Gan, Matthias Preusser +27 more

Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-2664

N/A

0DataRank · unranked

96 citations

Juan Manuel Sepúlveda-Sánchez, Timothy F. Cloughesy, Miguel Gil‐Gil, Vinay K. Puduvalli, Jeffrey J. Raizer +15 more

Data from Phase Ib/II Trial of Ribociclib in Combination with Binimetinib in Patients with NRAS-mutant Melanoma

(2023)10.1158/1078-0432.c.6532311

N/A

0DataRank · unranked

0 citations

Lisa Zimmer, Kevin B. Kim, Jeffrey A. Sosman, Paolo A. Ascierto, Michael A. Postow +10 more